Sunil Healthcare Yönetim

Yönetim kriter kontrolleri 3/4

Sunil Healthcare CEO'su Anil Khaitan, Aug2019 tarihinde atandı, in görev süresi 5.25 yıldır. in toplam yıllık tazminatı ₹ 3.00M olup, şirket hissesi ve opsiyonları dahil olmak üzere 100% maaş ve 0% ikramiyelerden oluşmaktadır. şirketin hisselerinin 57.95% ine doğrudan sahiptir ve bu hisseler ₹ 445.63M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 11.5 yıl ve 5.8 yıldır.

Anahtar bilgiler

Anil Khaitan

İcra Kurulu Başkanı

₹3.0m

Toplam tazminat

CEO maaş yüzdesi	100.0%
CEO görev süresi	5.3yrs
CEO sahipliği	57.9%
Yönetim ortalama görev süresi	11.5yrs
Yönetim Kurulu ortalama görev süresi	5.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Anil Khaitan'un ücretlendirmesi Sunil Healthcare'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	-₹13m
Jun 30 2024	n/a	n/a	-₹18m
Mar 31 2024	₹3m	₹3m	-₹18m
Dec 31 2023	n/a	n/a	-₹15m
Sep 30 2023	n/a	n/a	-₹14m
Jun 30 2023	n/a	n/a	₹19m
Mar 31 2023	₹3m	₹3m	₹67m
Dec 31 2022	n/a	n/a	₹102m
Sep 30 2022	n/a	n/a	₹125m
Jun 30 2022	n/a	n/a	₹104m
Mar 31 2022	₹3m	₹3m	₹64m
Dec 31 2021	n/a	n/a	₹18m
Sep 30 2021	n/a	n/a	-₹3m
Jun 30 2021	n/a	n/a	-₹2m
Mar 31 2021	₹3m	₹3m	-₹6m
Dec 31 2020	n/a	n/a	-₹7m
Sep 30 2020	n/a	n/a	-₹6m
Jun 30 2020	n/a	n/a	-₹18m
Mar 31 2020	₹3m	₹3m	-₹24m
Dec 31 2019	n/a	n/a	-₹21m
Sep 30 2019	n/a	n/a	-₹22m
Jun 30 2019	n/a	n/a	-₹9m
Mar 31 2019	₹3m	₹3m	-₹6m
Mar 31 2018	₹3m	₹3m	₹45m

Tazminat ve Piyasa: Anil 'ın toplam tazminatı ($USD 35.53K ) Indian pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 42.61K ).

Tazminat ve Kazançlar: Anil şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Anil Khaitan (68 yo)

5.3yrs

Görev süresi

₹3,000,000

Tazminat

Mr. Anil Kumar Khaitan has been Chief Executive Officer of Sunil Healthcare Ltd since August 14, 2019. He has been the Chairman of the Board at Sunil Healthcare Ltd. since August 1, 2007 and serves as its...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Anil Khaitan	Chairman	5.3yrs	₹3.00m	57.95% ₹ 445.6m
Pawan Rathi	Chief Financial Officer	no data	₹3.69m	Veri yok
Ishan Khaitan	President of Operation & Marketing	14.6yrs	₹2.96m	Veri yok
Satyendu Pattnaik	Deputy GM of Legal	2.3yrs	₹2.04m	Veri yok
Sarita Khaitan	Chief Strategic Officer	13.6yrs	₹2.80m	Veri yok
Kahaan Khaitan	President of Procurment	11.5yrs	₹2.96m	Veri yok
Santosh Deshprabhu	Senior VP & Plant Head	no data	₹3.84m	Veri yok

11.5yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim: 537253 'un yönetim ekibi deneyimli ve deneyimlidir ( 11.5 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Anil Khaitan	Chairman	40.1yrs	₹3.00m	57.95% ₹ 445.6m
Sanjay Kaushik	Non-Executive Director	21.4yrs	₹102.00k	Veri yok
Rakesh Mohan	Non-Executive-Independent Director	8yrs	₹68.00k	Veri yok
Harish Kumar	Non-Executive Independent Director	5.8yrs	₹93.50k	Veri yok
Krishna Rajan	Non-Executive Non-Independent Director	5.8yrs	₹51.00k	Veri yok
Bejon Misra	Non-Executive Independent Director	5.3yrs	₹76.50k	Veri yok
Mudita Chaturvedi	Non-Executive Independent Director	5yrs	₹42.50k	Veri yok

5.8yrs

Ortalama Görev Süresi

70yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 537253 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.8 yıldır).

Sunil Healthcare Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Sunil Healthcare Limited, Annual General Meeting, Sep 30, 2024

Sunil Healthcare Limited, Annual General Meeting, Sep 27, 2023

Insufficient new directors

Sunil Healthcare Limited Announces Company Secretary and Compliance Officer Changes

Sunil Healthcare Limited Announces Change in Designation of Sanjay Kumar Kaushik from Independent Director to Non-Executive Director

Insufficient new directors

Recent updates

Second quarter 2025 earnings released: ₹0.53 loss per share (vs ₹1.07 loss in 2Q 2024)

New major risk - Market cap size

Sunil Healthcare Limited to Report Q2, 2025 Results on Nov 13, 2024

First quarter 2025 earnings released: ₹0.67 loss per share (vs ₹0.63 loss in 1Q 2024)

Sunil Healthcare Limited, Annual General Meeting, Sep 30, 2024

Sunil Healthcare Limited to Report Q1, 2025 Results on Aug 13, 2024

Full year 2024 earnings released: ₹1.74 loss per share (vs ₹6.52 profit in FY 2023)

Sunil Healthcare Limited to Report Q4, 2024 Results on May 28, 2024

New minor risk - Share price stability

Third quarter 2024 earnings released: ₹0.20 loss per share (vs ₹0.08 loss in 3Q 2023)

Sunil Healthcare Limited to Report Nine Months, 2024 Results on Feb 14, 2024

Second quarter 2024 earnings released: ₹1.07 loss per share (vs ₹2.07 profit in 2Q 2023)

New minor risk - Profit margin trend

Sunil Healthcare Limited, Annual General Meeting, Sep 27, 2023

Sunil Healthcare Limited to Report Q1, 2024 Results on Aug 11, 2023

New major risk - Financial position

Investor sentiment deteriorates as stock falls 18%

Sunil Healthcare Limited to Report Q4, 2023 Results on May 29, 2023

Investor sentiment improves as stock rises 22%

Investor sentiment deteriorates as stock falls 26%

Third quarter 2023 earnings released: ₹0.08 loss per share (vs ₹3.03 profit in 3Q 2022)

Sunil Healthcare Limited to Report Q3, 2023 Results on Feb 14, 2023

Investor sentiment deteriorated over the past week

Second quarter 2023 earnings released: EPS: ₹2.07 (vs ₹0.04 in 2Q 2022)

Insufficient new directors

Sunil Healthcare Limited Announces Company Secretary and Compliance Officer Changes

Sunil Healthcare Limited to Report Q2, 2023 Results on Nov 14, 2022

Sunil Healthcare Limited Announces Change in Designation of Sanjay Kumar Kaushik from Independent Director to Non-Executive Director

Insufficient new directors

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Sunil Healthcare Limited Announces Resignation of Santosh Kumar Sharma as Company Secretary & Compliance Officer

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: ₹4.08 (vs ₹0.20 in 1Q 2022)

Sunil Healthcare Limited, Annual General Meeting, Sep 28, 2022

Sunil Healthcare Limited to Report Q1, 2023 Results on Jul 20, 2022

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: ₹6.26 (vs ₹0.62 loss in FY 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS ₹0.04 (vs ₹0.14 in 2Q 2021)

First quarter 2022 earnings released: EPS ₹0.20 (vs ₹0.19 loss in 1Q 2021)

Full year 2021 earnings released: ₹0.62 loss per share (vs ₹2.31 loss in FY 2020)

New 90-day high: ₹27.65

Third quarter 2021 earnings released: EPS ₹0.02

Sunil Healthcare Limited to Report Q3, 2021 Results on Jan 21, 2021

New 90-day low: ₹20.85

New 90-day low: ₹24.85

Second quarter 2021 earnings released: EPS ₹0.14

Sunil Healthcare Limited to Report Q2, 2021 Results on Oct 23, 2020

New 90-day high: ₹30.00

New 90-day high: ₹28.00

New 90-day high - ₹25.30

New 90-day high - ₹20.90

Sunil Healthcare Limited to Report Q1, 2021 Results on Jul 25, 2020

Sunil Healthcare Limited to Report Q4, 2020 Results on Jun 30, 2020

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş